FDA GCP Inspection Trends Identified Using AI
Presented Tuesday, June 14, 2022
Download this informative 1-hour presentation with insights into FDA GCP inspection trends, including intelligence on data integrity and clinical investigator enforcement activity.
- Jerry Chapman, Redica Systems
- Fran Lambetecchio, Regulatory Associates
What will be covered:
- Importance and challenges of human clinical studies
- Data sources and evaluation using AI Tools
- What we can learn from US FDA Inspections of Clinical Investigators
- A deeper dive into FDA Warning Letters and 483 data with some surprises
If you have any questions or comments, please do not hesitate to contact someone on our team at firstname.lastname@example.org or +1 (844) 332-3320.